ScholarIQanswers from OpenAlex

Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges

PaperCitations, authors & open-access status

Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges have?

ScholarIQcitation count

Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges has 72 citations in the OpenAlex counts ScholarIQ stores.

When was Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges published?

ScholarIQyear

Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges has 2014 year in the ScholarIQ index.

What is the open-access status of Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges?

ScholarIQoa status

Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges has closed oa status in the ScholarIQ index.

What is the DOI of Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges?

ScholarIQdoi

The DOI for Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges is on the source record.

What is the PMID of Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges?

ScholarIQpmid

The PMID for Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges is on the source record.

What is the OpenAlex record for Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges?

ScholarIQopenalex

The OpenAlex for Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial